Amy Winnen
BA, MBA
VP, STRATEGIC PARTNERSHIPS
Rochester, NY
It is in your hands, to make a better world for all who live in it."- Nelson Mandela
Areas of Expertise
- Initial company launches building out market and patient access strategies & organizational capabilities
- Establishing trade distribution channel strategies and contracting
- Integrating the patient perspective into strategy and operations
- Market Access data strategy, KPI development, and ongoing analytics
- Pricing strategy, contacting and pricing administration
- Packaging design to facilitate patient adherence
Biography
Amy Winnen has over 25 years of working with biotechnology and pharmaceutical companies across the go to market continuum to enable patient access. Her focus has been primarily with emerging companies translating promising science into organizational capabilities that have enabled successful new product launches. Amy has built, led, and developed teams across multiple functional areas including manufacturing/supply chain, trade, distribution, commercial operations, payer marketing, market access, patient services and patient advocacy.
Prior to joining AESARA, her recent industry leadership roles included Vice President, Head of Market Value, Access, Policy and Patient Affairs at Fulcrum Therapeutics, and Vice President, Market Access and Commercial Supply at Fennec Pharma. She has held other leadership roles across the commercialization and supply chain functions with Array BioPharma (Pfizer), Merrimack, Vertex Pharmaceuticals, and Millennium Pharmaceuticals (Takeda Oncology).
She holds an MBA from the Simmons School of Management in Boston, Massachusetts and a Bachelor of Arts in Economics and Sociology from St. Lawrence University in Canton, New York. Amy also holds a Certification in Reducing Racial Disparities in Healthcare from Harvard Business School.
Education
- MBA, Simmons University
- Certificate Program, Reducing Racial Disparities in Healthcare, Harvard Business School Online
- BA, Economics & Sociology, St. Lawrence University
My letter
While it’s the representation of a mathematical constant and irrational number; it has come to represent infinite possibilities and elusive to researchers. I believe patient access is a similar concept as constant need/focus for manufacturers yet at times is elusive. We can work together with our clients to help facilitate access with multiple approaches and possible solutions.
